standardized flow cytometry based assay for hcmv antiviral susceptibility.

NLM AIDSLINE Standardized flow cytometry based assay for HCMV antiviral susceptibility. McSharry J; Lurain N; Manischewitz J; Nokta M; Weinberg A; ACTG Flow
November 30, 1996

3rd Conf Retro and Opportun Infect. 1996 Jan 28-Feb 1;:156. Unique A flow cytometric assay has been developed for the rapid detection and quantitation of MRC-5 cells infected with human cytomegalovirus (HCMV). The ACTG Flow Cytometry/Virology Team has used this technique to develop a standardized method for the rapid determination of the susceptibility or resistance of HCMV clinical isolates to ganciclovir. MRC-5 cells were infected with either cell-free or cell-associated HCMV at an MOI of 0.01 to 1 infectious unit per cell. After incubation at 37C for 72 to 96 hr, in the presence or absence of various concentrations of ganciclovir, the cells were harvested, permeabilized with methanol, and treated with an FITC-labeled Mab to a nuclear HCMV IE antigen and a PE-labeled Mab to a cytoplasmic HCMV late antigen followed by FACS analysis. Using this assay, the ICSO of ganciclovir for AD169, the ganciclovir-sensitive strain of HCMV was between 1.0 and 3.0 micromolar, and the IC50 for each of two ganciclovir-resistant strains of HCMV, XbaF and D6/3/1, was greater than 12 micromolar. These results are in good agreement with the IC50 of the AD169, D6/3/1,and XbaF strains of HCMV obtained by the standard plaque reduction assay which takes approximately 14 days. The flow cytometric assay is rapid, taking only three to four days to complete, the data is collected mechanically as opposed to manual enumeration of stained foci using a microscope, and the assay is easily reproduced among laboratories. This assay should be useful for determining the sensitivity or resistance of HCMV to antiviral compounds that block viral DNA synthesis. Antibodies, Monoclonal/IMMUNOLOGY Antigens, Viral/IMMUNOLOGY Antiviral Agents/PHARMACOLOGY Cell Separation Cytomegalovirus/DRUG EFFECTS/GENETICS/PHYSIOLOGY DNA Replication/DRUG EFFECTS DNA, Viral Flow Cytometry Human Microbial Sensitivity Tests Reproducibility of Results ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies Climbing against gender-based violence: A quest for dignity, equality and justice Boehringer Ingelheim's Faldaprevir-Based Treatment Regimen Achieved Viral Cure in up to 80 Percent of Patients with Hepatitis C in Phase 3 Pivotal Trial Honduras reforms its penal code to end human right violations based on sexual orientation and gender identity Ohio hospital to pay for HIV-based bias Special event at the Commission on the Status of Women seeks to accelerate zero-tolerance towards gender-based violence through the AIDS response AUSTRALIA: Study Finds Protein Link to Sexually Transmitted Disease Susceptibility TEXAS: Zimbabwe-Based Artists' Exhibit Benefits AIDS Project CANADA: Edmonton Based Company Finding New Way To Test for HIV CANADA: McGill Launches Study on Seaweed-Based Gel That Prevents HPV
Information in this article was accurate in November 30, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.